A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.

Researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine using virus-like ...

Sino Biological has created a VLP protein platform based on the HEK293 expression system for producing full-length multi-pass transmembrane proteins (e.g. GPRC5D).

Creative Diagnostics has launched the Norovirus VP1 VLP Panel, a new research tool designed ... with only three known to infect humans. The virus protein 1 (VP1), a critical component in the ...

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced the launch of ...

7 This process enables greater recombinant protein yield due to increased GOI expression ... Scientists have created vaccines from virus-like particles (VLP), which are non-pathogenic nanoscale ...

The QIV is produced as virus-like particles (VLPs) consisting of a lipid bilayer studded with disease-specific protein antigens. Mimicking the native structure of viruses, VLPs are better ...

ProBioGen has expanded its protein and viral vector manufacturing capabilities at its Berlin headquarters, reinforcing its ...

He demonstrated that the display of a highly conserved single epitope from HPV L2 protein, on one of the surface-exposed loops of a bacteriophage VLP, induces antibodies that are highly ...

University of Leeds researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine ...